Cargando…
Opportunities and challenges of circulating biomarkers in neuroblastoma
Molecular analysis of nucleic acid and protein biomarkers is becoming increasingly common in paediatric oncology for diagnosis, risk stratification and molecularly targeted therapeutics. However, many current and emerging biomarkers are based on analysis of tumour tissue, which is obtained through i...
Autores principales: | Trigg, Ricky M., Shaw, Jacqui A., Turner, Suzanne D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Royal Society
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6544987/ https://www.ncbi.nlm.nih.gov/pubmed/31088252 http://dx.doi.org/10.1098/rsob.190056 |
Ejemplares similares
-
ALK in Neuroblastoma: Biological and Therapeutic Implications
por: Trigg, Ricky M., et al.
Publicado: (2018) -
Diagnostic accuracy of circulating-free DNA for the determination of MYCN amplification status in advanced-stage neuroblastoma: a systematic review and meta-analysis
por: Trigg, Ricky M., et al.
Publicado: (2020) -
Extracellular vesicles as circulating cancer biomarkers: opportunities and challenges
por: Lane, R. E., et al.
Publicado: (2018) -
Opportunities and challenges related to ferroptosis in glioma and neuroblastoma
por: Chi, Huizhong, et al.
Publicado: (2023) -
Exploring the Feasibility of Circulating miRNAs as Diagnostic and Prognostic Biomarkers in Osteoarthritis: Challenges and Opportunities
por: Felekkis, Kyriacos, et al.
Publicado: (2023)